GJB2 and sensorineural hearing loss disorder: Taking this background into consideration, we decided to carry out clinical and molecular delineation for a cohort of SNHL patients first by the Sanger sequencing of the GJB2 gene followed by whole exome sequencing (WES) for negative cases in an attempt to reach a more precise diagnosis for Egyptian SNHL patients.